Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Anal Chim Acta ; 1056: 79-87, 2019 May 16.
Article in English | MEDLINE | ID: mdl-30797464

ABSTRACT

Combination antiretroviral therapy (cART) regimens are recommended for HIV patients to better achieve and maintain plasma viral suppression. Despite adequate plasma viral suppression, HIV persists inside the brain, which is, in part thought to result from poor brain penetration of antiretroviral drugs. In this study, a simple and ultra-sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous determination of tenofovir, emtricitabine, and dolutegravir in cell lysates of an immortalized human brain microvascular endothelial cell line (hCMEC/D3) was developed and validated. Analytes were separated on a reverse phase C18 column using water and 0.1% formic acid in acetonitrile as mobile phases. The analytes were detected using positive electrospray ionization mode with multiple reaction monitoring (MRM). The assay was linear in the concentration range of 0.1-100 ng mL-1 for all analytes. Intra- and inter-assay precision and accuracy were within ±13.33% and ±10.53%, respectively. This approach described herein was used to determine the intracellular accumulation of tenofovir, emtricitabine, dolutegravir simultaneously in hCMEC/D3 cells samples.


Subject(s)
Anti-HIV Agents/analysis , Brain/cytology , Chromatography, Liquid/methods , Endothelial Cells/cytology , Intracellular Space/chemistry , Tandem Mass Spectrometry/methods , Analytic Sample Preparation Methods , Anti-HIV Agents/isolation & purification , Cell Line , Emtricitabine/analysis , Emtricitabine/isolation & purification , Heterocyclic Compounds, 3-Ring/analysis , Heterocyclic Compounds, 3-Ring/isolation & purification , Humans , Linear Models , Oxazines , Piperazines , Pyridones , Reproducibility of Results , Tenofovir/analysis , Tenofovir/isolation & purification
2.
Biomed Chromatogr ; 32(4)2018 Apr.
Article in English | MEDLINE | ID: mdl-29216682

ABSTRACT

A combination of antiretroviral agents is frequently used in effective treatment of the human immunodeficiency virus infection. In this study, two different separation methods are presented for the simultaneous determination of emtricitabine, rilpivirine and tenofovir from raw materials and urine samples. Developed liquid chromatography and capillary electrophoresis methods were thoroughly optimized for high analytical performances. Optimization of multiple variables at the same time by performing a minimum number of experiments was achieved by the Box-Behnken design, which is an experimental design in response surface methodology, in capillary electrophoresis. The results of the experimental design ensure minimum analysis time with well-separated analytes. Separation conditions, such as different stationary phases, pH level, organic modifiers and temperatures in liquid chromatography method, were also optimized. In particular, among stationary phases, the core-shell column especially enhanced the effectiveness of separation in liquid chromatography. Both methods were fully validated and applied to real samples. The main advantage of the developed methods is the separation of the drug combination in a short time with high efficiency and without any time-consuming steps.


Subject(s)
Anti-Retroviral Agents/urine , Chromatography, Liquid/methods , Electrophoresis, Capillary/methods , Emtricitabine/urine , Rilpivirine/urine , Tenofovir/urine , Anti-Retroviral Agents/chemistry , Anti-Retroviral Agents/isolation & purification , Emtricitabine/chemistry , Emtricitabine/isolation & purification , Humans , Limit of Detection , Linear Models , Models, Statistical , Reproducibility of Results , Rilpivirine/chemistry , Rilpivirine/isolation & purification , Tenofovir/chemistry , Tenofovir/isolation & purification
3.
Water Res ; 85: 57-65, 2015 Nov 15.
Article in English | MEDLINE | ID: mdl-26302215

ABSTRACT

In eThekwini, South Africa, the production of agricultural fertilizers from human urine collected from urine-diverting dry toilets is being evaluated at a municipality scale as a way to help finance a decentralized, dry sanitation system. The present study aimed to assess a range of human and environmental health hazards in source-separated urine, which was presumed to be contaminated with feces, by evaluating the presence of human pathogens, pharmaceuticals, and an antibiotic resistance gene. Composite urine samples from households enrolled in a urine collection trial were obtained from urine storage tanks installed in three regions of eThekwini. Polymerase chain reaction (PCR) assays targeted 9 viral and 10 bacterial human pathogens transmitted by the fecal-oral route. The most frequently detected viral pathogens were JC polyomavirus, rotavirus, and human adenovirus in 100%, 34% and 31% of samples, respectively. Aeromonas spp. and Shigella spp. were frequently detected gram negative bacteria, in 94% and 61% of samples, respectively. The gram positive bacterium, Clostridium perfringens, which is known to survive for extended times in urine, was found in 72% of samples. A screening of 41 trace organic compounds in the urine facilitated selection of 12 priority pharmaceuticals for further evaluation. The antibiotics sulfamethoxazole and trimethoprim, which are frequently prescribed as prophylaxis for HIV-positive patients, were detected in 95% and 85% of samples, reaching maximum concentrations of 6800 µg/L and 1280 µg/L, respectively. The antiretroviral drug emtricitabine was also detected in 40% of urine samples. A sulfonamide antibiotic resistance gene (sul1) was detected in 100% of urine samples. By coupling analysis of pathogens and pharmaceuticals in geographically dispersed samples in eThekwini, this study reveals a range of human and environmental health hazards in urine intended for fertilizer production. Collection of urine offers the benefit of sequestering contaminants from environmental release and allows for targeted treatment of potential health hazards prior to agricultural application. The efficacy of pathogen and pharmaceutical inactivation, transformation or removal during urine nutrient recovery processes is thus briefly reviewed.


Subject(s)
Anti-Bacterial Agents/urine , Antiviral Agents/urine , Gram-Negative Bacteria/isolation & purification , Gram-Positive Bacteria/isolation & purification , Urine/microbiology , Urine/virology , Anti-Bacterial Agents/isolation & purification , Antiviral Agents/isolation & purification , Drug Resistance, Microbial/genetics , Emtricitabine/isolation & purification , Emtricitabine/urine , Health Impact Assessment , Humans , South Africa , Sulfamethoxazole/isolation & purification , Sulfamethoxazole/urine , Trimethoprim/isolation & purification , Trimethoprim/urine
SELECTION OF CITATIONS
SEARCH DETAIL
...